Reduction in phencyclidine induced sensorimotor gating deficits in the rat following increased system xc − activity in the medial prefrontal cortex

Reduced Prefrontal-Parietal Effective Connectivity and Working Memory Deficits in Schizophrenia

(2012) L. Deserno et al.   JOURNAL OF NEUROSCIENCE

Behavioral phenotyping of glutathione-deficient mice: Relevance to schizophrenia and bipolar disorder

(2011) Anita Kulak et al.   BEHAVIOURAL BRAIN RESEARCH

Decreased glutathione levels and impaired antioxidant enzyme activities in drug-naive first-episode schizophrenic patients

(2011) Monia Raffa et al.   BMC Psychiatry

System xc- cystine/glutamate antiporter: an update on molecular pharmacology and roles within the CNS

(2011) Richard J Bridges et al.   BRITISH JOURNAL OF PHARMACOLOGY

Regulation of the System x−C cystine/glutamate exchanger by intracellular glutathione levels in rat astrocyte primary cultures

(2011) Todd Michael Seib et al.   GLIA

From Revolution to Evolution: The Glutamate Hypothesis of Schizophrenia and its Implication for Treatment

(2011) Bita Moghaddam et al.   NEUROPSYCHOPHARMACOLOGY

Time course of the attenuation effect of repeated antipsychotic treatment on prepulse inhibition disruption induced by repeated phencyclidine treatment

(2011) Ming Li et al.   PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

Astrocytic regulation of cortical UP states

(2011) K. E. Poskanzer et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Genetic Dysregulation of Glutathione Synthesis Predicts Alteration of Plasma Thiol Redox Status in Schizophrenia

(2010) René Gysin et al.   ANTIOXIDANTS & REDOX SIGNALING

Qualitative Methods in Early-Phase Drug Trials

(2010) Michael Berk et al.   JOURNAL OF CLINICAL PSYCHIATRY

COMT Val108/158Met genotype modulates human sensory gating

(2010) Tomislav Majic et al.   NEUROIMAGE

Reversing cocaine-induced synaptic potentiation provides enduring protection from relapse

(2010) K. Moussawi et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The glutamatergic compounds sarcosine and N-acetylcysteine ameliorate prepulse inhibition deficits in metabotropic glutamate 5 receptor knockout mice

(2010) Hwei-Hsien Chen et al.   PSYCHOPHARMACOLOGY

Left dorsolateral prefrontal cortex dysfunction in medication-naive schizophrenia

(2010) Nicoletta M.J. van Veelen et al.   SCHIZOPHRENIA RESEARCH

N-Acetylcysteine reverses cocaine-induced metaplasticity

(2009) Khaled Moussawi et al.   NATURE NEUROSCIENCE

The functional neuroanatomy of symptom dimensions in schizophrenia: A qualitative and quantitative review of a persistent question

(2009) Vina M. Goghari et al.   NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

N-Acetyl Cysteine as a Glutathione Precursor for Schizophrenia—A Double-Blind, Randomized, Placebo-Controlled Trial

(2008) Michael Berk et al.   BIOLOGICAL PSYCHIATRY

Cortical grey matter volume and sensorimotor gating in schizophrenia

(2008) Veena Kumari et al.   CORTEX

Blunted cystine–glutamate antiporter function in the nucleus accumbens promotes cocaine-induced drug seeking

(2008) K.S. Kau et al.   NEUROSCIENCE

Negative Correlation between Brain Glutathione Level and Negative Symptoms in Schizophrenia: A 3T 1H-MRS Study

(2008) Daisuke Matsuzawa et al.   PLoS One

Realistic expectations of prepulse inhibition in translational models for schizophrenia research

(2008) Neal R. Swerdlow et al.   PSYCHOPHARMACOLOGY

Working memory and DLPFC inefficiency in schizophrenia: The FBIRN study

(2008) S. G. Potkin et al.   SCHIZOPHRENIA BULLETIN